Home Infusion Therapy Market by Product (Infusion Pumps, Ambulatory Infusion Pumps, Intravenous Sets, IV cannulas, Needleless Connectors), Application (Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parental Nutrition, Specialty Pharmaceuticals, Others): Global Market Size Estimates and Forecast (2022-2030)

Code: BMIRE00026820 | Pages: 100 | Industry: Medical Device | Date: Oct 2022 | Type: Global


The market crossed the US$ 28.14 billion mark in 2022 and is expected to hit US$ 67.76  billion by 2030, recording a CAGR of 11.61% during the forecast period.

Logistics, and patient centricity, will fuel the growth of the market.

General healthcare trends, such as decentralization of care and consumerism, have created an environment that is receptive to home infusion. Due to the COVID-19 pandemic, forces moving infusion services into the home (such as the risk of acquiring infections in healthcare facilities) are magnified and accelerated. As a result, a surge in the use of home infusion is expected in the future. As pharmaceutical manufacturers are growing and evolving go-to-market plans for these infusion products, the changes brought about by home infusion are carefully considered and integrated into go-to-market strategies.  

Within the report, the market is segmented into product and application. Based on product, the market is segmented into infusion pumps, ambulatory, intravenous sets, iv cannulas, and needleless connectors. Ambulatory infusion pumps are further sub-segmented into insulin pumps, syringe pumps, elastomeric pumps, patient-controlled analgesics, and volumetric pumps. Based on application, the market is segmented into anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parental nutrition, specialty pharmaceuticals, and others. Geographically, the market is sub-segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Advantages related to home infusion therapy will empower the growth of the market.

Home infusion expands the access for patients who cannot easily travel to an outpatient location to receive an injection (due to personal or geographic limitations). Patient adherence and compliance to infusion therapy are improved by home infusion since the patient’s burden of responsibility is lower relative to intakes that occur outside the home. The ability to receive infusion care in the home causes less disruption to the patient’s daily life and increases patient comfort. Also, home infusion costs less than care provided in the hospital outpatient setting; for patients with high cost-sharing percentages (including Medicare patients), a home infusion can reduce the overall cost burden.

Changes in lifestyle diseases will surge the growth of the market.

A lifestyle change will surge the growth of infusion therapy and increase the diabetic population, and a reduction in treatment costs will also trigger the growth of this market. Many complicated medical conditions and illnesses can be treated with these infusion therapies, reducing the hospital and the cost of treatment. Home infusion therapies are safer as the physicians observe the drug administration. Reimbursement policies in various public and private forms will also boost the growth of this market.

Recent strategic developments in the home infusion therapy market

The home infusion therapy market has undergone several significant developments, and a few of these have been mentioned below:

  • On Jun. 2, 2021, Baxter launched the shared source analytics 1.0 digital health module to enhance the clinical management of home dialysis patients. Share source analytics 1.0 is a clinical management resource within the sharesource remote patient management platform that provides healthcare professionals with a comprehensive dashboard containing simplified trend data from their home dialysis patients’ treatments.
  • On Sept. 21, 2021,  B. Braun Medical Inc., a leader in infusion therapy and pain management, launched its new CARE SAFE IV Administration Sets with an Optional AirStop component. CARESAFE IV Sets are the first robust portfolio of IV administration sets in the US market that are not made with polyvinyl chloride (PVC) and diethylhexyl phthalate

Several players drive the home infusion therapy market by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships Baxter International,Inc; B. Braun; CareFusion Corporation; ICU Medical, Inc; Fresenius Kabi AG, JMS Co. Ltd.;Terumo Group; ICU Medical, Inc.; Caesarea Medical Electronics Ltd.; Abbott Healthcare Private Limited are among the prominent players operating in the market.


The target audience for the report:

  • Government bodies, such as regulating authorities and policymakers
  • End users
  • Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented based on:

  • Product:
  • Infusion Pumps
  • Ambulatory Infusion Pumps
  • Insulin Pumps
  • Syringe Pumps
  • Elastomeric Pumps
  • Patient-Controlled Analgesics
  • Volumetric Pumps
  • Intravenous Sets
  • IV cannulas
  • Needleless Connectors
  • Application:
  • Anti-Infective
  • Endocrinology
  • Hydration Therapy
  • Chemotherapy
  • Enteral Nutrition
  • Parental Nutrition
  • Specialty Pharmaceuticals
  • Others


  • Region
    • North America
    • Europe
    • Asia Pacific (APAC)
    • South & Central America
    • Middle East & Africa
  • Companies profiled
    • Baxter International, Inc
    • B. Braun
    • CareFusion Corporation
    • ICU Medical, Inc
    • Fresenius Kabi AG
    • JMS Co. Ltd.
    • Terumo Group
    • ICU Medical, Inc.
    • Caesarea Medical Electronics Ltd.
    • Abbott Healthcare Private Limited



The List of Companies
- Baxter International, Inc
- B. Braun
- CareFusion Corporation
- ICU Medical, Inc
- Fresenius Kabi AG
- JMS Co. Ltd.
- Terumo Group
- ICU Medical, Inc.
- Caesarea Medical Electronics Ltd.
- Abbott Healthcare Private Limited

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Purchase Options
Single User License
Site License
Enterprise License